Cargando…
Non-small Cell Lung Cancer with Multiple Brain Metastases Treated with Radiosurgery and Erlotinib: A Case Report
Brain metastases are commonly seen complications in non-small cell lung cancer (NSCLC) patients. The incidence of brain metastases is increasing as a result of more effective systemic targeted therapies with prolonged survival. The prognosis is usually poor, and up to six months of median survivals...
Autores principales: | Sahin, Bilgehan, Mustafayev, Teuta, Aydin, Gokhan, Gungor, Gorkem, Yapici, Bulend, Atalar, Banu, Ozyar, Enis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832407/ https://www.ncbi.nlm.nih.gov/pubmed/29507851 http://dx.doi.org/10.7759/cureus.2003 |
Ejemplares similares
-
First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience
por: Sahin, Bilgehan, et al.
Publicado: (2019) -
Long-term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients with Centrally Located Thoracic Tumors
por: Atalar, Banu, et al.
Publicado: (2020) -
Multichannel Film Dosimetry for Quality Assurance of Intensity Modulated Radiotherapy Treatment Plans Under 0.35 T Magnetic Field
por: Gungor, Gorkem, et al.
Publicado: (2020) -
Evaluation of response to stereotactic radiosurgery in patients with radioresistant brain metastases
por: Sayan, Mutlay, et al.
Publicado: (2019) -
Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020)